2024. Down Staging of Cirrhosis in All Cirrhotic Patients with HCV Genotype 3-a Infection, Treated with 12-Weeks Triple Therapy, Including Sofosbuvir, Daclatasvir and Ribavirin. Medical Forum Monthly. 29, 3 (May 2024).